JoinCells is a pioneering entity in hematopoietic stem cell (HSC) expansion, leveraging the potential of umbilical cord blood to address hematologic and rare blood disorders. Our novel ex vivo expansion method aims to facilitate prompt off-the-shelf HSC transplantations. This innovation not only serves a broader patient demographic from a single unit but also maintains cellular integrity for enduring functionality. JoinCells is committed to alleviating the prolonged donor matching process inherent in hematologic disease treatment, propelling us closer to a future where high-quality HSC transplants are readily accessible

Visit site